SubsidieMeestersDiagnosis of large vessel occlusion (LVO) in acute stroke for improving access to treatment
LVOCheck is a portable diagnostic tool that rapidly identifies large vessel occlusion in stroke patients using a blood drop, enabling faster treatment and improving patient outcomes.
Projectdetails
Introduction
LVOCheck is a portable diagnostic solution providing fast identification of large vessel occlusion (LVO) in acute stroke, just by analyzing a blood drop from the patient's fingerpick.
Rapid Triage
LVOCheck allows rapid triage of stroke patients already in the ambulance, so patients suffering a LVO can be directly driven to the closest thrombectomy centre to get the clot removed, without the need of a cranial CT scan at the nearest hospital.
This approach avoids unnecessary patient transfers and waiting times, saving thereby an average of 2 hours from symptom onset to treatment. Our pilot studies have shown a clinical benefit of 15-20% more patients becoming asymptomatic or functionally independent.
Cost-Effectiveness and Scalability
LVOCheck is a cost-effective, worldwide scalable innovation that will transform the triage and treatment of stroke patients, lessening the enormous economic and social burden of stroke.
Impact on Treatment
The use of LVOCheck will dramatically shorten the time from stroke onset to therapy, reducing disability, and saving lives.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.772.276 |
| Totale projectbegroting | € 3.960.395 |
Tijdlijn
| Startdatum | 1-5-2023 |
| Einddatum | 30-4-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- ADVANCED BRAIN COMPANION DIAGNOSTICS SPAIN SLpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Transformational crossing system to prevent amputation and treat complex chronic total occlusions in critical limb ischemiaVersono's CTO guidewire uses ultrasound to enable endovascular surgeons to effectively treat 90% of chronic total occlusions, aiming to restore blood flow and prevent limb amputation in CLTI patients. | EIC Accelerator | € 2.478.175 | 2023 | Details |
Empowering physicians to provide every stroke treatment with the right treatment in time, with StrokeFlowStrokeFlow aims to revolutionize stroke care by providing real-time patient data and tailored treatment solutions, reducing delays and improving outcomes for stroke patients. | EIC Accelerator | € 2.235.809 | 2023 | Details |
To deliver the first medical treatment dedicated to patients with haemorrhagic strokeNANOp2lysis develops O2L-001, a safe, effective thrombolytic agent for intracerebral hematoma treatment via a single injection, enhancing delivery and reducing side effects post-hemorrhagic stroke. | EIC Accelerator | € 2.500.000 | 2022 | Details |
EDV2209 – a Paradigm shift in the treatment of stroke.Edvince aims to revolutionize stroke treatment with its innovative drug EDV2209, enhancing cerebral blood flow to prevent brain damage from severe subarachnoid hemorrhage. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Paradigm shift in stroke: accurate diagnosis and evaluation of all treatment options in any hospital, at any timeMethinks aims to transform stroke diagnosis by enabling all hospitals to evaluate treatment options using standard imaging, reducing time-to-treatment and improving patient outcomes globally. | EIC Accelerator | € 2.495.415 | 2023 | Details |
Transformational crossing system to prevent amputation and treat complex chronic total occlusions in critical limb ischemia
Versono's CTO guidewire uses ultrasound to enable endovascular surgeons to effectively treat 90% of chronic total occlusions, aiming to restore blood flow and prevent limb amputation in CLTI patients.
Empowering physicians to provide every stroke treatment with the right treatment in time, with StrokeFlow
StrokeFlow aims to revolutionize stroke care by providing real-time patient data and tailored treatment solutions, reducing delays and improving outcomes for stroke patients.
To deliver the first medical treatment dedicated to patients with haemorrhagic stroke
NANOp2lysis develops O2L-001, a safe, effective thrombolytic agent for intracerebral hematoma treatment via a single injection, enhancing delivery and reducing side effects post-hemorrhagic stroke.
EDV2209 – a Paradigm shift in the treatment of stroke.
Edvince aims to revolutionize stroke treatment with its innovative drug EDV2209, enhancing cerebral blood flow to prevent brain damage from severe subarachnoid hemorrhage.
Paradigm shift in stroke: accurate diagnosis and evaluation of all treatment options in any hospital, at any time
Methinks aims to transform stroke diagnosis by enabling all hospitals to evaluate treatment options using standard imaging, reducing time-to-treatment and improving patient outcomes globally.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
StrokePointerTrianecT ontwikkelt StrokePointer, een medisch EEG-apparaat voor ambulancepersoneel om binnen 3 minuten LVO-herseninfarcten te detecteren, met als doel snellere en betere patiëntverzorging. | Mkb-innovati... | € 20.000 | 2023 | Details |
STRICT (STRoke diagnostiC Tool)Dit project onderzoekt de haalbaarheid van een ambulance-test voor het vaststellen van beroerte-type via bloed-RNA's, om snelle behandeling en herstel te bevorderen. | Mkb-innovati... | € 20.000 | 2022 | Details |
Advancing stroke care with cutting-edge ultrasound biomarkers for Neurocritical CareResolve Stroke aims to enhance ultrasound imaging with the SYLVER system to improve stroke diagnosis and management through innovative biomarkers, making timely detection more accessible and effective. | EIC Transition | € 2.493.436 | 2025 | Details |
Monitoring of stroke patients with 3D ultrasound localization microscopyThe ERC POC StrokeMonitor project aims to validate a portable super-resolution ultrasound device for monitoring delayed cerebral ischemia in stroke patients, enhancing neuroimaging accessibility and accuracy. | ERC Proof of... | € 150.000 | 2023 | Details |
Project MITH Nico.labDit project onderzoekt de haalbaarheid van EEG-herseninfarct triage in ambulances met AI-algoritmen om snel en nauwkeurig patiënten te identificeren voor directe behandeling. | Mkb-innovati... | € 20.000 | 2020 | Details |
StrokePointer
TrianecT ontwikkelt StrokePointer, een medisch EEG-apparaat voor ambulancepersoneel om binnen 3 minuten LVO-herseninfarcten te detecteren, met als doel snellere en betere patiëntverzorging.
STRICT (STRoke diagnostiC Tool)
Dit project onderzoekt de haalbaarheid van een ambulance-test voor het vaststellen van beroerte-type via bloed-RNA's, om snelle behandeling en herstel te bevorderen.
Advancing stroke care with cutting-edge ultrasound biomarkers for Neurocritical Care
Resolve Stroke aims to enhance ultrasound imaging with the SYLVER system to improve stroke diagnosis and management through innovative biomarkers, making timely detection more accessible and effective.
Monitoring of stroke patients with 3D ultrasound localization microscopy
The ERC POC StrokeMonitor project aims to validate a portable super-resolution ultrasound device for monitoring delayed cerebral ischemia in stroke patients, enhancing neuroimaging accessibility and accuracy.
Project MITH Nico.lab
Dit project onderzoekt de haalbaarheid van EEG-herseninfarct triage in ambulances met AI-algoritmen om snel en nauwkeurig patiënten te identificeren voor directe behandeling.